1. Home
  2. STVN vs RLI Comparison

STVN vs RLI Comparison

Compare STVN & RLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STVN
  • RLI
  • Stock Information
  • Founded
  • STVN 1949
  • RLI 1965
  • Country
  • STVN Italy
  • RLI United States
  • Employees
  • STVN N/A
  • RLI N/A
  • Industry
  • STVN Containers/Packaging
  • RLI Property-Casualty Insurers
  • Sector
  • STVN Consumer Discretionary
  • RLI Finance
  • Exchange
  • STVN Nasdaq
  • RLI Nasdaq
  • Market Cap
  • STVN 6.2B
  • RLI 6.1B
  • IPO Year
  • STVN 2021
  • RLI 1985
  • Fundamental
  • Price
  • STVN $22.96
  • RLI $67.74
  • Analyst Decision
  • STVN Buy
  • RLI Hold
  • Analyst Count
  • STVN 4
  • RLI 7
  • Target Price
  • STVN $25.13
  • RLI $78.60
  • AVG Volume (30 Days)
  • STVN 341.4K
  • RLI 445.6K
  • Earning Date
  • STVN 08-05-2025
  • RLI 10-20-2025
  • Dividend Yield
  • STVN 0.27%
  • RLI 3.90%
  • EPS Growth
  • STVN 6.78
  • RLI N/A
  • EPS
  • STVN 0.57
  • RLI 3.50
  • Revenue
  • STVN $1,344,798,591.00
  • RLI $1,816,602,000.00
  • Revenue This Year
  • STVN $8.24
  • RLI N/A
  • Revenue Next Year
  • STVN $10.38
  • RLI $3.71
  • P/E Ratio
  • STVN $40.05
  • RLI $19.35
  • Revenue Growth
  • STVN 5.28
  • RLI 11.69
  • 52 Week Low
  • STVN $17.12
  • RLI $65.14
  • 52 Week High
  • STVN $28.00
  • RLI $91.15
  • Technical
  • Relative Strength Index (RSI)
  • STVN 47.98
  • RLI 48.28
  • Support Level
  • STVN $21.51
  • RLI $67.39
  • Resistance Level
  • STVN $23.72
  • RLI $68.69
  • Average True Range (ATR)
  • STVN 0.84
  • RLI 0.90
  • MACD
  • STVN 0.09
  • RLI 0.21
  • Stochastic Oscillator
  • STVN 65.77
  • RLI 55.38

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

About RLI RLI Corp. (DE)

RLI Corp underwrites property and casualty insurance through its subsidiaries. The company offers insurance coverage in the specialty admitted market, where the products are designed for special risks. It also offers products in the excess and surplus markets, which provides an alternative for customers with risks or loss exposures that generally cannot be written in the standard admitted market. RLI distributes property and casualty insurance through its wholly-owned branch offices that market to wholesale and retail producers. The company's insurance operation segments include Casualty, Property, and Surety and it derives a majority of its revenue from the Casualty segment.

Share on Social Networks: